Dexmedetomidine vs Propofol on the Recordings of Deep Brain Activity Measured Through Implanted Stimulators (DEXPROPAR)

Clinical Trial ID NCT02256319

PubWeight™ 0.00‹?›

🔗 Visit the ClinicalTrials.gov page for NCT02256319

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson's disease. N Engl J Med 2003 6.59
2 Bilateral subthalamic nucleus stimulation for Parkinson's disease: a systematic review of the clinical literature. Neurosurgery 2005 1.24
3 Involvement of the subthalamic nucleus in impulse control disorders associated with Parkinson's disease. Brain 2010 1.15
4 Clinical experience with dexmedetomidine for implantation of deep brain stimulators in Parkinson's disease. Anesth Analg 2006 1.11
5 Anaesthesia for deep brain stimulation and in patients with implanted neurostimulator devices. Br J Anaesth 2009 1.06
6 Characterisation of tremor-associated local field potentials in the subthalamic nucleus in Parkinson's disease. Eur J Neurosci 2009 0.95
7 Beta activity in the subthalamic nucleus during sleep in patients with Parkinson's disease. Mov Disord 2009 0.85
8 Safety in the use of dexmedetomidine (precedex) for deep brain stimulation surgery: our experience in 23 randomized patients. Neuromodulation 2012 0.76
Next 100